Related Experiment Videos

[A clinical study on the diagnosis of spinal cord tumor using magnetic resonance imaging]

T Yuyama1

  • 1Department of Orthopaedic Surgery, School of Medicine, Chiba University, Japan.

Nihon Seikeigeka Gakkai Zasshi
|October 1, 1989
PubMed

Insights

Magnetic resonance imaging (MRI) effectively diagnoses spinal cord tumors, identifying their level and type. Contrast enhancement with Dimeglumine gadopentetate (Gd-DTPA) further improves tumor visualization and differentiation.

Area of Science:

  • Neurology
  • Radiology
  • Oncology

Context:

  • Spinal cord tumors present diagnostic challenges.
  • Accurate tumor characterization is crucial for treatment planning.

Purpose:

  • To evaluate the diagnostic utility of magnetic resonance imaging (MRI) for spinal cord tumors.
  • To assess the efficacy of Dimeglumine gadopentetate (Gd-DTPA) contrast enhancement in MRI.

Summary:

  • MRI accurately determined tumor level and differentiated intramedullary from extramedullary lesions.
  • MRI diagnosed various tumor types including lipoma, arteriovenous malformation, and hematoma.
  • Gd-DTPA enhanced MRI in most cases, improving tumor content visualization and differentiation from edema/syrinx.

Impact:

  • MRI is a valuable tool for diagnosing spinal cord tumors.
  • Gd-DTPA enhanced MRI aids in detailed tumor characterization, guiding clinical management.

Related Concept Videos